 | • レポートコード：MRC2012A5548 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、肝疾患治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。肝疾患治療薬の種類別市場規模（経口、注射）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：F. Hoffmann-La Roche、Angion Biomedica、Johnson & Johnson、Gilead Sciences、AbbVie、GlaxoSmithKline、LG Life Sciences、Achillion Pharmaceuticals、Merck、Bayer、Verva Pharmaceuticals、Phenex Pharmaceuticals、Shenzhen Kangtai Biological Products、ProMetic Life Sciences、Raptor Pharmaceuticals、 ・地域別グローバル市場分析 2015年-2020年 ・肝疾患治療薬の北米市場（アメリカ、カナダ、メキシコ） ・肝疾患治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・肝疾患治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・肝疾患治療薬の南米市場（ブラジル、アルゼンチン） ・肝疾患治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、注射 ・用途別分析：病院、診療所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Liver Diseases Therapeutics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Liver Diseases Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Liver Diseases Therapeutics Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Liver Diseases Therapeutics Drugs market has been segmented into
Oral
Injection
By Application, Liver Diseases Therapeutics Drugs has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Liver Diseases Therapeutics Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Liver Diseases Therapeutics Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Liver Diseases Therapeutics Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Liver Diseases Therapeutics Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Liver Diseases Therapeutics Drugs Market Share Analysis
Liver Diseases Therapeutics Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Liver Diseases Therapeutics Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Liver Diseases Therapeutics Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Liver Diseases Therapeutics Drugs are:
F. Hoffmann-La Roche
Angion Biomedica
Johnson & Johnson
Gilead Sciences
AbbVie
GlaxoSmithKline
LG Life Sciences
Achillion Pharmaceuticals
Merck
Bayer
Verva Pharmaceuticals
Phenex Pharmaceuticals
Shenzhen Kangtai Biological Products
ProMetic Life Sciences
Raptor Pharmaceuticals
Among other players domestic and global, Liver Diseases Therapeutics Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liver Diseases Therapeutics Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liver Diseases Therapeutics Drugs, with price, sales, revenue and global market share of Liver Diseases Therapeutics Drugs in 2018 and 2019.
Chapter 3, the Liver Diseases Therapeutics Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liver Diseases Therapeutics Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Liver Diseases Therapeutics Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Liver Diseases Therapeutics Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Liver Diseases Therapeutics Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Liver Diseases Therapeutics Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Liver Diseases Therapeutics Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Overview of Global Liver Diseases Therapeutics Drugs Market
1.4.1 Global Liver Diseases Therapeutics Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 F. Hoffmann-La Roche
2.1.1 F. Hoffmann-La Roche Details
2.1.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 F. Hoffmann-La Roche SWOT Analysis
2.1.4 F. Hoffmann-La Roche Product and Services
2.1.5 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Angion Biomedica
2.2.1 Angion Biomedica Details
2.2.2 Angion Biomedica Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Angion Biomedica SWOT Analysis
2.2.4 Angion Biomedica Product and Services
2.2.5 Angion Biomedica Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Gilead Sciences
2.4.1 Gilead Sciences Details
2.4.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Gilead Sciences SWOT Analysis
2.4.4 Gilead Sciences Product and Services
2.4.5 Gilead Sciences Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AbbVie SWOT Analysis
2.5.4 AbbVie Product and Services
2.5.5 AbbVie Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline SWOT Analysis
2.6.4 GlaxoSmithKline Product and Services
2.6.5 GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 LG Life Sciences
2.7.1 LG Life Sciences Details
2.7.2 LG Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 LG Life Sciences SWOT Analysis
2.7.4 LG Life Sciences Product and Services
2.7.5 LG Life Sciences Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Achillion Pharmaceuticals
2.8.1 Achillion Pharmaceuticals Details
2.8.2 Achillion Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Achillion Pharmaceuticals SWOT Analysis
2.8.4 Achillion Pharmaceuticals Product and Services
2.8.5 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck SWOT Analysis
2.9.4 Merck Product and Services
2.9.5 Merck Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bayer SWOT Analysis
2.10.4 Bayer Product and Services
2.10.5 Bayer Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Verva Pharmaceuticals
2.11.1 Verva Pharmaceuticals Details
2.11.2 Verva Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Verva Pharmaceuticals SWOT Analysis
2.11.4 Verva Pharmaceuticals Product and Services
2.11.5 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Phenex Pharmaceuticals
2.12.1 Phenex Pharmaceuticals Details
2.12.2 Phenex Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Phenex Pharmaceuticals SWOT Analysis
2.12.4 Phenex Pharmaceuticals Product and Services
2.12.5 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Shenzhen Kangtai Biological Products
2.13.1 Shenzhen Kangtai Biological Products Details
2.13.2 Shenzhen Kangtai Biological Products Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Shenzhen Kangtai Biological Products SWOT Analysis
2.13.4 Shenzhen Kangtai Biological Products Product and Services
2.13.5 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 ProMetic Life Sciences
2.14.1 ProMetic Life Sciences Details
2.14.2 ProMetic Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 ProMetic Life Sciences SWOT Analysis
2.14.4 ProMetic Life Sciences Product and Services
2.14.5 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Raptor Pharmaceuticals
2.15.1 Raptor Pharmaceuticals Details
2.15.2 Raptor Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Raptor Pharmaceuticals SWOT Analysis
2.15.4 Raptor Pharmaceuticals Product and Services
2.15.5 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Liver Diseases Therapeutics Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Liver Diseases Therapeutics Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Liver Diseases Therapeutics Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Liver Diseases Therapeutics Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Liver Diseases Therapeutics Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Liver Diseases Therapeutics Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Liver Diseases Therapeutics Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.5 South America Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Liver Diseases Therapeutics Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Liver Diseases Therapeutics Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Liver Diseases Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Liver Diseases Therapeutics Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Liver Diseases Therapeutics Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Liver Diseases Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.3 UK Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.4 France Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Liver Diseases Therapeutics Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Liver Diseases Therapeutics Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Liver Diseases Therapeutics Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.5 India Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Liver Diseases Therapeutics Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Liver Diseases Therapeutics Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Liver Diseases Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Liver Diseases Therapeutics Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Liver Diseases Therapeutics Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Liver Diseases Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Liver Diseases Therapeutics Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Liver Diseases Therapeutics Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Liver Diseases Therapeutics Drugs Price by Type (2015-2020)
11 Global Liver Diseases Therapeutics Drugs Market Segment by Application
11.1 Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2015-2020)
11.2 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Liver Diseases Therapeutics Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Liver Diseases Therapeutics Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Liver Diseases Therapeutics Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Liver Diseases Therapeutics Drugs Market Forecast (2021-2025)
12.2.2 Europe Liver Diseases Therapeutics Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Liver Diseases Therapeutics Drugs Market Forecast (2021-2025)
12.2.4 South America Liver Diseases Therapeutics Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Liver Diseases Therapeutics Drugs Market Forecast (2021-2025)
12.3 Liver Diseases Therapeutics Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Liver Diseases Therapeutics Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Liver Diseases Therapeutics Drugs Market Share Forecast by Type (2021-2025)
12.4 Liver Diseases Therapeutics Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Liver Diseases Therapeutics Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Liver Diseases Therapeutics Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Liver Diseases Therapeutics Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Liver Diseases Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Liver Diseases Therapeutics Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 8. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Major Business
Table 9. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 10. F. Hoffmann-La Roche SWOT Analysis
Table 11. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Product and Services
Table 12. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Angion Biomedica Basic Information, Manufacturing Base and Competitors
Table 14. Angion Biomedica Liver Diseases Therapeutics Drugs Major Business
Table 15. Angion Biomedica Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Angion Biomedica SWOT Analysis
Table 17. Angion Biomedica Liver Diseases Therapeutics Drugs Product and Services
Table 18. Angion Biomedica Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Liver Diseases Therapeutics Drugs Major Business
Table 21. Johnson & Johnson Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Johnson & Johnson SWOT Analysis
Table 23. Johnson & Johnson Liver Diseases Therapeutics Drugs Product and Services
Table 24. Johnson & Johnson Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 26. Gilead Sciences Liver Diseases Therapeutics Drugs Major Business
Table 27. Gilead Sciences Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Gilead Sciences SWOT Analysis
Table 29. Gilead Sciences Liver Diseases Therapeutics Drugs Product and Services
Table 30. Gilead Sciences Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. AbbVie Basic Information, Manufacturing Base and Competitors
Table 32. AbbVie Liver Diseases Therapeutics Drugs Major Business
Table 33. AbbVie Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 34. AbbVie SWOT Analysis
Table 35. AbbVie Liver Diseases Therapeutics Drugs Product and Services
Table 36. AbbVie Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 38. GlaxoSmithKline Liver Diseases Therapeutics Drugs Major Business
Table 39. GlaxoSmithKline Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 40. GlaxoSmithKline SWOT Analysis
Table 41. GlaxoSmithKline Liver Diseases Therapeutics Drugs Product and Services
Table 42. GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 44. LG Life Sciences Liver Diseases Therapeutics Drugs Major Business
Table 45. LG Life Sciences Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 46. LG Life Sciences SWOT Analysis
Table 47. LG Life Sciences Liver Diseases Therapeutics Drugs Product and Services
Table 48. LG Life Sciences Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Achillion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 50. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Major Business
Table 51. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Achillion Pharmaceuticals SWOT Analysis
Table 53. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Product and Services
Table 54. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Merck Basic Information, Manufacturing Base and Competitors
Table 56. Merck Liver Diseases Therapeutics Drugs Major Business
Table 57. Merck Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Merck SWOT Analysis
Table 59. Merck Liver Diseases Therapeutics Drugs Product and Services
Table 60. Merck Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer Liver Diseases Therapeutics Drugs Major Business
Table 63. Bayer Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Bayer SWOT Analysis
Table 65. Bayer Liver Diseases Therapeutics Drugs Product and Services
Table 66. Bayer Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Verva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Major Business
Table 69. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Verva Pharmaceuticals SWOT Analysis
Table 71. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Product and Services
Table 72. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Phenex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Major Business
Table 75. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Phenex Pharmaceuticals SWOT Analysis
Table 77. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Product and Services
Table 78. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Shenzhen Kangtai Biological Products Basic Information, Manufacturing Base and Competitors
Table 80. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Major Business
Table 81. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Shenzhen Kangtai Biological Products SWOT Analysis
Table 83. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Product and Services
Table 84. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. ProMetic Life Sciences Basic Information, Manufacturing Base and Competitors
Table 86. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Major Business
Table 87. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 88. ProMetic Life Sciences SWOT Analysis
Table 89. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Product and Services
Table 90. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Raptor Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 92. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Major Business
Table 93. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 94. Raptor Pharmaceuticals SWOT Analysis
Table 95. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Product and Services
Table 96. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Liver Diseases Therapeutics Drugs Sales by Manufacturer (2018-2019) (K Pcs)
Table 98. Global Liver Diseases Therapeutics Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Liver Diseases Therapeutics Drugs Sales by Regions (2015-2020) (K Pcs)
Table 100. Global Liver Diseases Therapeutics Drugs Sales Market Share by Regions (2015-2020)
Table 101. Global Liver Diseases Therapeutics Drugs Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Liver Diseases Therapeutics Drugs Sales by Countries (2015-2020) (K Pcs)
Table 103. North America Liver Diseases Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 104. North America Liver Diseases Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Liver Diseases Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 106. Europe Liver Diseases Therapeutics Drugs Sales by Countries (2015-2020) (K Pcs)
Table 107. Europe Liver Diseases Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 108. Europe Liver Diseases Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Liver Diseases Therapeutics Drugs Sales by Regions (2015-2020) (K Pcs)
Table 110. Asia-Pacific Liver Diseases Therapeutics Drugs Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Liver Diseases Therapeutics Drugs Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Liver Diseases Therapeutics Drugs Sales by Countries (2015-2020) (K Pcs)
Table 113. South America Liver Diseases Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 114. South America Liver Diseases Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Liver Diseases Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Liver Diseases Therapeutics Drugs Sales by Countries (2015-2020) (K Pcs)
Table 117. Middle East & Africa Liver Diseases Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Liver Diseases Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Liver Diseases Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 120. Global Liver Diseases Therapeutics Drugs Sales by Type (2015-2020) (K Pcs)
Table 121. Global Liver Diseases Therapeutics Drugs Sales Share by Type (2015-2020)
Table 122. Global Liver Diseases Therapeutics Drugs Revenue by Type (2015-2020) (USD Million)
Table 123. Global Liver Diseases Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 124. Global Liver Diseases Therapeutics Drugs Sales by Application (2015-2020) (K Pcs)
Table 125. Global Liver Diseases Therapeutics Drugs Sales Share by Application (2015-2020)
Table 126. Global Liver Diseases Therapeutics Drugs Sales Forecast by Regions (2021-2025) (K Pcs)
Table 127. Global Liver Diseases Therapeutics Drugs Market Share Forecast by Regions (2021-2025)
Table 128. Global Liver Diseases Therapeutics Drugs Sales Forecast by Type (2021-2025) (K Pcs)
Table 129. Global Liver Diseases Therapeutics Drugs Market Share Forecast by Type (2021-2025)
Table 130. Global Liver Diseases Therapeutics Drugs Sales Forecast by Application (2021-2025)
Table 131. Global Liver Diseases Therapeutics Drugs Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Liver Diseases Therapeutics Drugs Picture
Figure 2. Global Sales Market Share of Liver Diseases Therapeutics Drugs by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. Liver Diseases Therapeutics Drugs Sales Market Share by Application in 2018
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Other Picture
Figure 9. Global Liver Diseases Therapeutics Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Liver Diseases Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Liver Diseases Therapeutics Drugs Sales Market Share by Manufacturer in 2019
Figure 30. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Liver Diseases Therapeutics Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Liver Diseases Therapeutics Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 35. Global Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Regions (2015-2020)
Figure 37. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Regions in 2018
Figure 38. North America Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 39. Europe Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 41. South America Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 43. North America Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Liver Diseases Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Figure 45. North America Liver Diseases Therapeutics Drugs Sales Market Share by Countries in 2018
Figure 46. North America Liver Diseases Therapeutics Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Liver Diseases Therapeutics Drugs Revenue Market Share by Countries in 2018
Figure 48. United States Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 49. Canada Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 50. Mexico Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Europe Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Liver Diseases Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Liver Diseases Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 54. Germany Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. UK Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. France Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Italy Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Asia-Pacific Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Liver Diseases Therapeutics Drugs Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Liver Diseases Therapeutics Drugs Revenue Market Share by Regions 2019
Figure 62. China Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Japan Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Korea Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. India Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Southeast Asia Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. South America Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Liver Diseases Therapeutics Drugs Sales Market Share by Countries in 2019
Figure 69. South America Liver Diseases Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 70. Brazil Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Argentina Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Egypt Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Turkey Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. South Africa Liver Diseases Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Global Liver Diseases Therapeutics Drugs Sales and Growth Rate (2021-2025) (K Pcs)
Figure 81. Global Liver Diseases Therapeutics Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Liver Diseases Therapeutics Drugs Market Forecast (2021-2025) (K Pcs)
Figure 83. Europe Sales Liver Diseases Therapeutics Drugs Market Forecast (2021-2025) (K Pcs)
Figure 84. Asia-Pacific Sales Liver Diseases Therapeutics Drugs Market Forecast (2021-2025) (K Pcs)
Figure 85. South America Sales Liver Diseases Therapeutics Drugs Market Forecast (2021-2025) (K Pcs)
Figure 86. Middle East & Africa Sales Liver Diseases Therapeutics Drugs Market Forecast (2021-2025) (K Pcs)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
慢性肝疾患治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chronic Liver Diseases Therapeutics Market The global Chronic Liver Diseases Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and hig…- 慢性肝疾患治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Chronic Liver Diseases Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 肝硬変治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Liver Cirrhosis Therapeutics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Liver Cirr…
- 非アルコール性脂肪肝疾患治療薬の世界市場（～2026年） Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …
- 肝硬変治療薬の世界市場（～2026年） Market Analysis and Insights: Global Liver Cirrhosis Therapeutics Market The global Liver Cirrhosis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Liver Cirrhosis Therapeutics Scope and Market Size Liver …